Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo

Journal of Neuro-Oncology

Volumn 40, Issue 3, 1998, Pages 197-203

  Yoshioka, Hiroyuki ^a   Hama, Seiji ^a   Sadatomo, Takashi ^a   Taniguchi, Eiji ^a   Harada, Kunyu ^a   Sugiyama, Kazuhiko ^a   Kimura, Fumihiko ^b   Motoyoshi, Kazuo ^b   Kurisu, Kaoru ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Glioma; M CSF gene; Macrophage; Natural killer cell; Tumorigenesis

Indexed keywords

ANTIBIOTIC G 418; ANTIBODY; COLONY STIMULATING FACTOR 1; GANGLIOTETRAOSYLCERAMIDE; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC TRANSFECTION; GLIOMA CELL; GROWTH RATE; HISTOLOGY; MACROPHAGE; NONHUMAN; RAT; TUMOR CELL LINE;

EID: 0032426064     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006177328576     Document Type: Article

References (51)

1. Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mahaley MS: A randomized comparison of intraarterial versus intravenous BCNA, with or without intravenous 5-flourouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 76: 772-781, 1992
2. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuche K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozumi T, Matsutani M, Nomura K: Effects of ACNU and radiotherapy on malignant gliomas. J Neurosurg 64: 53-57, 1986
3. Riddell SR, Greenberg PD, Ovcrcll RW: Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology. Hum Gene Ther 3: 319-338, 1992
4. Hatake K, Motoyoshi K, Ishizaka Y, Takaku F, Miura Y: Purification of human urinary colony stimulating factor by high performance liquid chromatography. J Chromatogr 344: 339-344, 1985
5. Becker S, Warren MK, Haskill S: Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol 139: 3703-3709, 1987
6. Wong GG, Temple PA, Leary AC, Witek-Giannotti JS, Yang YC, Ciarletta AB, Chung M, Murtha P, Kriz R, Kaufman RJ, Ferenz CR, Sibley BS, Turner KJ, Hewick RM, Clark SC, Yanai N, Yokota H, Yamada M, Saito M, Motoyoshi K, Takaku F: Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 235: 1504-1508, 1987
7. Warren MK, Ralph P: Macrophage growth factor CSF-1 stimulates human monocyte production of interferon. tumor necrosis factor and colony-stimulating activity. J Immunol 137: 2281-2285, 1986
8. WangJM, GriffinJD, Rambaldi A, Gue Chen Z, Mantovani A: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 141: 575-579, 1988
9. Ralph P, Nakoinz I: Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1. Cell Immunol 105: 270-279, 1987
10. Wing EJ, Waheed A, Shadduck RK, Nagle ES, Stephenson K: Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity. J Clin Invest 69: 270-276, 1982
11. Sampson JA, Carlino JA: Enhancement of human monocyte tumoricidal activity by recombinant M-CSF. J Immunol 141: 3680-3686, 1988
12. Douzono M, Suzu S, Yamada M, Yanai N, Kawashima T, Hatake K, Motoyoshi K: Augmentation of cancer chemotherapy by preinjection of human macrophage colony-stimulating factor in L1210 leukemic cell-inoculated mice. Jpn J Cancer Res 86: 315-321, 1995
13. Sagone AL, Leuko JJ; Human monocyte to macrophage differentiation in vivo; characterization and mechanisms of the increased antibody-dependent cytotoxicity associated with differentiation. J Leukocyte Biol 35: 217-228, 1984
14. Munn DH, Cheung NK: Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays. J Exp Med 170: 511-526, 1989
15. Morita T, Ikeda K, Douzono M, Yamada M, Kimura F, Kawakami K, Sasaki K, Motoyoshi K, Takahara J, Irino S: Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 88: 955-961, 1996
16. Bock SN, Cameron RB, Kragel P, Mule JJ, Rosenberg SA: Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice. Cancer Res 51: 2649-2654, 1991
17. Lu L, Shen RN, Lin ZH, Aukerman SL, Ralph P, Broxmeyer HE: Anti-tumor effects of recombinant human macrophage colony-stimulating factor, alone or in combination with local irradiation, in mice inoculated with Lewis lung carcinoma cells. Int J Cancer 47: 143-147, 1991
18. Hume DA, Donahue RE, Fidler IJ; The therapeutic effect of human recombinant macrophage colony stimulating factor (CSF-1) in experimental murine metastatic melanoma. Lymphokine Res 8: 69-77, 1989
19. Vallera DA, Taylor PA, Aukerman SL, Blazar BR: Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2. Cancer Res 53: 4273-4280, 1993
20. Matsuoka T, Uozumi T, Kurisu K, Maeda H, Kawamoto K, Monden S: Antitumor effects of human recombinant macrophage colony-stimulating factor against, rat brain tumors. Biotherapy 8: 51-62, 1994
21. Heike Y, Sonc S, Yano S, Seimiya H, Tsuruo T, Ogura T: M-CSF gene transduction in multidrug-resistant human cancer cells to enhance anti-P-glycoprotein antibody-dependent macrophage-mediated cytotoxicity. Int J Cancer 54: 851-857, 1993
22. Harada K, Yoshida J, Mizuno M, Kurisu K, Uozumi T: Growth inhibition of intracerebral rat glioma by transfection-induced human interferon-β. J Surg Oncol 59: 105-109, 1995
23. Harada K, Yoshida J, Mizuno M, Sugita K, Kurisu K, Uozumi T; Growth inhibition of subcutancously transplanted human glioma by transfection-induced tumor necrosis factor-alpha and augmentation of the effect by γ-interferon. J Neuro-Oncol 22: 221-225, 1994
24. Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W: Current Protocols in Immunology. Greene and Wiley-Interscience, New York, 1991
25. Tay CH, Welsh RM, Brutkiewicz RR: NK cell response to viral infections in β2-microglobulm-deficient mice. J Immunol 154: 780-789, 1995
26. McKnight AJ, Zimmer GJ, Fogelman I, Wolf SF, Abbas AK: Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 152: 2172-2179, 1994
27. Yamashiro S, Takcya M, Nishi T, Kuratsu J, Yoshimura T, Ushio Y, Takahashi K: Tumor-derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am J Pathol 145; 856-867, 1994
28. Chan JK, Tsang WY, Pau MY; Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol 26: 1139-1143, 1995
29. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39: 741-748, 1991
30. Blankenstein T, Qin ZH, Uberla K, Muller W, Rosen H, Volk HD, Diamantstein T: Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med 173: 1047-1052, 1991
31. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E: Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity, Cancer Res 50: 7820-7825, 1990
32. Porgador A, Bannerji R, Watanabe Y, Feldman M, Gilboa E, Eisenbach L: Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells. J Immunol 150: 1458-1470, 1993
33. Bottazzi B, Walter S, Govoni D, Colotta F, Mantovani A: Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol 148: 1280-1285, 1992
34. Connor J, Bannerji R, Saito S, Heston W, Fair W, Gilboa E: Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells. J Exp Med 177: 1127-1134, 1993
35. Golumbek PT, Lazenby AJ, Levitsky HI, Jaffee LM, Karasuyarna H, Baker M, Pardoll DM: Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254: 713-716, 1991
36. Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L: Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res 52: 3679-3686, 1992
37. Colombo MP, Ferrari G, Stoppacciaro A, Parenza M, Rodolfo M, Mavilio F, Parmiani G: Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo. J Exp Med 173: 889-897, 1991
38. Sanda MG, Ayyagari SR, Jaffee EM, Epstein JT, Clift SL, Cohen LK, Dranoff G, Pardoll DM, Mulligan RC, Simons JW: Demonstration of a rational strategy for human prostate cancer gene therapy. J Urol 151: 622-628, 1994
39. Kimura F, Douzono M, Ohta J, Morita T, Ikeda K, Nakamura Y, Sato K, Yamada M, Nagata N, Motoyoshi K; Augmentation of antitumor immunity using genetically M-CSF-expressing L1210 cells. Exp Hematol 24: 360-363, 1996
40. Morita T, Ikeda K, Douzono M, Yamada M, Kimura F, Kawakami K, Sasaki K, Motoyoshi K, Takahara J, Irino S: Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice. Blood 88: 955-961, 1996
41. Sanda MG, Bolton E, Mule JJ, Rosenberg SA: In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells. J Immunother 12: 132-137, 1992
42. Munn DH, Cheung NK: Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med 172: 231-237, 1990
43. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC: Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 119: 182-192, 1989
44. Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, Saito M, Takaku F, Motoyoshi K; Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 49: 5913-5917, 1989
45. Wing EJ, Ampel NM, Waheed A, Shadduck RK: Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol 135: 2052-2056, 1985
46. Motoyoshi K, Yoshida K, Hatake K, Saito M, Miura Y, Yanai N, Yamada M, Kawashima T, Wong GG, Temple PA, Leadry AC, Witek-Giannoti JS, Fujisawa M, Yuo A, Okabe T, Takaku F: Recombinant and native human urinary colony-stimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes. Exp Hematol 17: 68-71, 1989
47. Moore RN, Oppenheim JJ, Farrar JJ, Carter CS Jr, Waheed A, Shadduck RK: Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors. J Immunol 125: 1302-1305, 1980
48. Oster W, Brach MA, Gruss HJ, Mertelsmann R, Herrmann F: Interleukin-1β (IL-1β) expression in human blood mononuclear phagocytes is differentially regulated by granulocyte-macrophage colony-stimulating factor (GM-CSF), M-CSF, and IL-3. Blood 79: 1260-1265, 1992
49. Stuehr DJ, Nathan CF: Nitric oxide, A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543-1555, 1989
50. Bukowski RM, Budd GT, Gibbons JA, Bauer RJ, Childs A, Antal J, Finke J, Tuason L, Lorenzi V, McLain D: Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor; clinical and immunomodulatory effects. J Clin Oncol 12: 97-106, 1994
51. Zeigler ZR, Rosenfeld CS, Nemunaitis JJ, Besa EC, Shadduck RK: Increased macrophage colony-stimulating factor levels in immune thrombocytopenic purpura. Blood 81: 1251-1254, 1993